Keith A. Goldan

CIK 1495411 · Chief Financial Officer · last filed 2026-06-02

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$4.47M

Companies

5

Total Filings

35

Lifetime Open-Market Net

-$196.5K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
SNDX	Chief Financial Officer	139,252	$18.25	$2.54M	-$195.4K	14	2026-06-02
ABEO	Director	32,751	$5.53	$181.1K	$0	1	2026-04-07
OptiNose, Inc. (OPTN) Delisted	Chief Financial Officer	141,726	$9.60	$1.36M	-$13.7K	13	2022-03-17
Fibrocell Science, Inc. (FCSC) Delisted	SVP and CFO	2,000	—	—	$12.7K	2	2016-03-02
PATH	CFO and VP	166,066	$10.55	$1.75M	$0	4	2013-01-22

Recent Filings · Page 4 of 4

35 filings

Form 4 transactions across all companies, newest first.

Filed	Symbol	Action	Net Shares	Net $	Link
2014-02-25	—	Mixed	−166,066	-$1.13M
2013-01-22	PATH	Grant (A)	+125,000	$0	EDGAR
2013-01-09	PATH	Mixed	+36,274	$0	EDGAR
2012-03-27	PATH	Grant (A)	—	$0	EDGAR
2010-08-12	PATH	Conv (C)	+4,792	$7.7K	EDGAR

Showing 31–35 of 35

Prev Page 4 of 4

Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.